Skip to main navigation Skip to search Skip to main content

Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S.

  • Wiley D. Jenkins
  • , Lauren B. Beach
  • , John Schneider
  • , Samuel R. Friedman
  • , Mai T. Pho
  • , Suzan Walters
  • , Jerel Ezell
  • , April M. Young
  • , Caitie Hennessy
  • , William C. Miller
  • , Vivian F. Go
  • , Christina Sun
  • , David W. Seal
  • , Ryan P. Westergaard
  • , Heidi M. Crane
  • , Rob J. Fredericksen
  • , Stephanie A. Ruderman
  • , Scott Fletcher
  • , Jimmy Ma
  • , J. A. Delaney
  • Karma Plaisance, Judith Feinberg, Gordon S. Smith, P. Todd Korthuis, Thomas J. Stopka, Peter D. Friedmann, William Zule, Mike Winer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Introduction: People who use drugs (PWUD) are at risk of HIV infection, but the frequency and distribution of transmission-associated behaviors within rural communities is not well understood. Further, while interventions designed to more explicitly affirm individuals' sexual orientation and behaviors may be more effective, descriptions of behavior variability by orientation are lacking. We sought to describe how disease transmission behaviors and overdose risk vary by sexual orientation and activity among rural PWUD. Methods: From 01/2018–03/2020, rural PWUD participating in the Rural Opioid Initiative were surveyed across 8 sites. Collected data included: demographics; experiences with drug use, overdose, and healthcare; stigma; gender identity; and sexual orientation and partners. Participants were categorized as: monosexual by orientation and behavior (Mono-only), monosexual by orientation but behaviorally bisexual (Mono/Bi), and bisexual by orientation (Bi+). Analyses included descriptive summaries, bivariate examination (chi-square), and logistic regression (relative risk [RR] and 95 % confidence interval [CI]). Results: The 1455 participants were 84.8 % Mono-only, 3.2 % Mono/Bi, and 12.0 % Bi+. Compared to Mono-only men, Mono/Bi and Bi+ men had greater risk of transactional sex (RR = 9.71, CI = 6.66–14.2 and RR = 5.09, CI = 2.79–9.27, respectively) and sharing syringes for injection (RR = 1.58, CI = 1.06–2.35 and RR = 1.85, CI = 1.38–2.47). Compared to Mono-only women, Mono-Bi and Bi+ women had greater risk of transactional sex (RR = 4.47, CI = 2.68–7.47 and RR = 2.63, CI = 1.81–3.81); and Bi+ women had greater risk of sharing syringes for injection (RR = 1.49, CI = 1.23–1.81), sharing syringes to mix drugs (RR = 1.44, CI = 1.23–1.69), and experiencing an overdose (RR = 1.32, CI = 1.12–1.56). Bi+ men and women both more frequently reported selling sex as a source of income (versus Mono-only, both p < 0.050) and measures of perceived stigma (all p < 0.050). Conclusions: Rural PWUD who are bisexual by orientation or behavior are significantly more likely to engage in behaviors associated with infectious disease transmission and to experience stigma and drug overdose. Given the growing recognition of bisexuality as a distinct orientation that warrants individualized consideration, interventions that are specifically acknowledging and affirming to the circumstances of this group are needed.

Original languageEnglish
Article number209629
JournalJournal of substance use and addiction treatment
Volume171
DOIs
StatePublished - Apr 2025

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Inc.

Funding

This publication is based upon data collected and/or methods developed as part of the Rural Opioid Initiative (ROI), a multi-site study with the goal of better characterizing the rural opioid epidemic and its consequences and a common protocol that was developed collaboratively by investigators at eight research institutions and at the National Institute on Drug Abuse (NIDA), the Appalachian Regional Commission (ARC), the Centers for Disease Control and Prevention (CDC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). Research presented in this manuscript is the result of secondary data harmonization and analysis and was supported by grant U24DA048538 from NIDA. Primary data collection was supported by grants UG3DA044829/UH3DA044829, UG3DA044798/UH3DA044798, UG3DA044830/UH3DA044830, UG3DA044823/UH3DA044823, UH3DA044822/UH3DA044822, UG3DA044831/UH3DA044831, UG3DA044825, UG3DA044826/UH3DA044826, U24DA044801, and UL1TR002369 co-funded by NIDA, ARC, CDC, and SAMHSA. The authors thank the other ROI investigators and their teams, community and state partners, and the participants of the individual ROI studies for their valuable contributions. A full list of participating ROI institutions and other resources can be found at http://ruralopioidinitiative.org. This publication is based upon data collected and/or methods developed as part of the Rural Opioid Initiative (ROI), a multi-site study with the goal of better characterizing the rural opioid epidemic and its consequences and a common protocol that was developed collaboratively by investigators at eight research institutions and at the National Institute on Drug Abuse (NIDA), the Appalachian Regional Commission (ARC), the Centers for Disease Control and Prevention (CDC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). Research presented in this manuscript is the result of secondary data harmonization and analysis and was supported by grant U24DA048538 from NIDA . Primary data collection was supported by grants UG3DA044829/UH3DA044829 , UG3DA044798/UH3DA044798 , UG3DA044830/UH3DA044830 , UG3DA044823/UH3DA044823 , UH3DA044822/UH3DA044822 , UG3DA044831/UH3DA044831 , UG3DA044825 , UG3DA044826/UH3DA044826 , U24DA044801 , and UL1TR002369 co-funded by NIDA , ARC , CDC , and SAMHSA .

FundersFunder number
Centers for Disease Control and Prevention
Automotive Research and Testing Center
Appalachian Regional Commission
Rural Opioid Initiative
Substance Abuse and Mental Health Services AdministrationU24DA048538
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseUG3DA044829/UH3DA044829, UL1TR002369, UH3DA044822/UH3DA044822, UG3DA044798/UH3DA044798, UG3DA044826/UH3DA044826, UG3DA044823/UH3DA044823, UG3DA044831/UH3DA044831, UG3DA044830/UH3DA044830, UG3DA044825, U24DA044801

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Infectious Disease
    • Overdose
    • People who use drugs
    • Rural

    ASJC Scopus subject areas

    • Medicine (miscellaneous)
    • Psychiatric Mental Health
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S.'. Together they form a unique fingerprint.

    Cite this